Shots:
- Bausch + Lomb has received the US FDA’s approval for Lumify Preservative Free eye drops to treat ocular redness due to minor eye irritations
- The studies demonstrated low incidence of side effects such as rebound redness and loss of efficacy over time with Lumify Preservative Free eye drops. The company plans its availability in early 2025 as single-use vials
- Lumify is a free preservative eye drop that contains OTC brimonidine tartrate’s low dose 0.025% for treating ocular redness
Ref: Bausch + Lomb | Image: Bausch + Lomb| Press Release
Related News:- The US FDA Grants Accelerated Approval to Day One’s Ojemda for Treating Pediatric Low-Grade Glioma (pLGG)
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
